Huntington's Disease Cortical Organoids
Source Galimberti et al., 2024 · University of Milan, Department of Biosciences · 10.1038/s41467-024-50877-x
Abstract
This protocol describes the generation of three-dimensional telencephalic organoids from isogenic human ESC lines (RUES2) that recapitulate ventral and dorsal telencephalic identities. The protocol enables the study of neurodevelopmental alterations and cell-autonomous and non-cell autonomous mechanisms in Huntington's disease by allowing co-culture of healthy and disease-bearing cells within a single organoid.
Protocol overview
15 steps across 5 phases
- a Culture human ESCs on Geltrex-coated plates
- b Prepare cells for organoid aggregation
- c Seed cells in V-bottom 96-well plate
- a Replace medium with Neural Induction Medium
- b Perform partial medium changes
- a Add morphogens for ventral patterning
- b Continue partial medium changes during patterning
- a Transfer organoids to 6 cm² dish on orbital shaker
- b Embed organoids in Geltrex matrix
- c Switch to Neuronal Differentiation Medium
- d Perform partial medium changes during maturation
- e Continue culture until Day 120
- a Generate stable GFP and TOMATO-expressing cell lines via lentiviral transduction
- b Co-aggregate CTRL and HD cells at 1:1 ratio
- c Harvest mosaic organoids at Day 120 and FACS sort
Full SOP
Full SOPs need an account and a plan
Create an account, then get free Academic access (for verified academics) or choose a plan. Plans include step-by-step procedures, reagent concentrations, QC checklists and batch record templates.
Create an accountAlready registered? Log in
Attribution
This SOP was written by Organthis based on the published method in Galimberti et al., 2024. Once the originating laboratory has confirmed it, the SOP is marked Verified.
Something wrong with this entry? Report an issue with this protocol